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LETTERS TO THE EDITOR
Regarding “The Carotid Surgery for Ischemic Stroke
trial”
Dr Eckstein and colleagues are to be congratulated on the
results of their prospective observational multicenter trial on the
safety of carotid endarterectomy (CEA) after a nondisabling isch-
emic stroke.1 From March 1997 to August 2000, a remarkable 164
patients experiencing nondisabling stroke underwent CEA within
the first 6 weeks of onset of the neurologic event. The perioperative
stroke and mortality rate was 6.7% (11 of 164 patients), with a
crude perioperative stroke rate of 6.1% (10 of 164 patients). On the
basis of these findings, the authors concluded that early CEA,
within 6 weeks after a related ischemic stroke, carries perioperative
mortality and stroke rates comparable to those reported in con-
trolled multicenter randomized trials.2,3
We recently looked at this issue, prospectively comparing
perioperative outcome between patients with a carotid lesion and
ipsilateral nondisabling stroke who underwent early CEA, ie,
within 30 days, or delayed CEA, ie, more than 30 days after the
neurologic event.4 Over 48 months, all patients who had a non-
disabling ischemic stroke and were referred to our section and
scheduled for elective CEA were invited to take part in a prospec-
tive randomized early versus delayed CEA protocol. Of the 92
patients who met inclusion criteria, 86 agreed to the randomiza-
tion protocol and 6 refused. Forty-five patients were randomized
to receive CEA within 30 days of stroke (median, 18 days; range,
15-30 days), and 41 patients were to receive CEA more than 30
days after stroke (median, 59 days; range, 38-120 days). No
perioperative deaths occurred in either group. Perioperative stroke
incidence was comparable in the two groups (1 of 45 patients [2%]
vs 1 of 41 patients [2%]; both strokes were ipsilateral to the side
operated on and occurred within the first 12 hours of CEA, and
both were minor. No new stroke occurred during the waiting
period in the delayed group, nor were there any late strokes in
either group. No patients had perioperative cerebral hemorrhage,
the most feared complication of early CEA, confirming that this
catastrophic event is rare after early CEA. Both neurologic events
were probably the outcome of small embolisms occurring during
carotid dissection or coming from the endarterectomized site
when blood flow was restored, bearing no relationship to timing of
surgery. This finding correlates closely with that reported by Eck-
stein et al,1 showing that even in this patient population the most
common cause of perioperative failure is technical error and can
thus be averted by improving the technical aspects of the surgical
procedure.5 The study by Eckstein and colleagues, like our own,
provides further evidence that timing of surgery does not influence
benefit of CEA in this patient population. There are also several
considerations, mentioned in the medical literature, that might
well tip the balance in favor of early CEA, ie, risk for recurrent
stroke during the waiting period, complications of interval warfarin
sodium therapy or other special regimens, interruption of physical
therapy programs, and, last, the huge stress engendered in some
patients by the waiting period.
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Regarding “New method to create a vascular
arteriovenous fistula in the arm with an endoscopic
technique”
We read with interest the technical article by Hayakawa et al,1
who describe a minimally invasive technique for harvesting the
upper arm basilic vein for creation of vascular access. This tech-
nique is similar to endoscopic harvesting of the saphenous vein in
the leg for use in peripheral arterial and coronary artery bypass
grafting.2,3 Hayakawa and colleagues report 10 patients who re-
ceived treatment with this endoscopic technique with a commer-
cially available device, with satisfying results. Such video-assisted
endoscopic techniques may be superior to conventional basilic vein
transposition in terms of fewer postoperative complications, eg,
infection, hematoma, seroma formation, and edema, as a result of
extensive skin flap dissection. Moreover, vascular access cannula-
tion may be carried out in an early phase because of improved
wound healing.
The authors raised the suggestion that this technique has not
been described before, as can be established from the listed refer-
ences. However, Martinez et al4 were the first to report on endo-
scopic basilic vein transposition, and we have also reported our
experience.5 In these reports, small series of 9 and 12 patients,
respectively, were operated on with use of various endoscopic
devices to harvest the basilic vein. The outcome in both studies was
similar, with a low incidence of complications and patency ranging
from 75% to 88% after 1 year of follow-up.
Several devices for minimal invasive harvesting are commer-
cially available. Subcutaneous access may be achieved with balloons
introduced and expanded in the subcutaneous tissue with gas
inflation or with expandable devices to create space for dissection
of structures. The Maastricht group developed a custom-made
dissection hook, suitable for introduction of a 5 mm endoscope.
Standard endoscopic instruments were used for vein dissection and
harvesting. In all of our patients, a complete endoscopic technique
was feasible without conversion to open surgical vein harvesting.
The advantages of this new method are obvious: small inci-
sions with less risk for hematoma, edema, and cutaneous nerve
damage. In addition, because of the small incisions, postoperative
pain may be minimal and early cannulation may be possible.
In concordance with Hayakawa and colleagues, we conclude
that video-assisted endoscopic basilic vein transposition is a prom-
ising surgical technique for creation of vascular access in patients
undergoing dialysis.
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